Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
This is a defining moment for the company’s integrity, long-term viability, and moral compass. The core tension is between short-term financial protection and long-term trust, legal exposure, and—most importantly—patient safety. Ethically and legally, the company has a duty to act on credible safety signals.Read the full answer